BioElectronics Corporation (BIEL)

Market Cap	11.12M +125.0%
Revenue (ttm)	1.61M +94.0%
Net Income	-289.82K
EPS	-0.00
Shares Out	24.71B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,276,944
Average Volume	12,792,767
Open	0.0004
Previous Close	0.0004
Day's Range	0.0004 - 0.0005
52-Week Range	0.0001 - 0.0014
Beta	2.07
RSI	58.70
Earnings Date	n/a

About BioElectronics

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIEL

Financial Performance

In 2021, BioElectronics's revenue was $1.61 million, an increase of 94.01% compared to the previous year's $829,563. Losses were -$289,821, -75.01% less than in 2020.